急性肝卟啉病中的肝细胞癌:美国卟啉病联盟纵向研究结果
该多中心纵向横断面分析评估了327例急性肝卟啉病(AHP)患者,5例(1.5%)诊断为肝细胞癌(HCC),其中4例为急性间歇性卟啉病、1例为变异型卟啉病。HCC诊断中位年龄69岁,均无肝硬化,部分患者无临床症状。作者认为AHP患者无论有无临床发作均应自50岁起筛查HCC。
要点
- 327例AHP患者中5例(1.5%)诊断HCC,4例为急性间歇性卟啉病、1例为变异型卟啉病。
- HCC诊断中位年龄69岁,所有患者均为白人女性,均无肝硬化。
- 作者建议AHP患者无论有无临床发作均应自50岁起筛查HCC。
核心结论
- 在美国这项研究中,1.5%的AHP患者患有HCC。
- AHP中的HCC发生在无肝硬化的情况下,这与其他慢性肝病形成对比。
- AHP患者无论临床发作与否,均应自50岁起筛查HCC。
- AHP中肝癌发生的发病机制未知,需要进一步研究。
研究设计与样本
- 多中心纵向研究中的横断面分析,评估AHP患者的HCC情况。
- 共纳入327例AHP患者。
主要发现
- 327例AHP患者中5例(1.5%)诊断为HCC,其中4例为急性间歇性卟啉病、1例为变异型卟啉病,经生化和/或基因检测证实。
- 5例HCC患者均为白人女性,诊断时中位年龄27岁(范围21-75岁),HCC诊断中位年龄69岁(范围61-74岁)。
- AHP无症状者2例,偶发发作者2例,复发发作者1例(>4次/年)。
- 所有患者肝脏影像显示单个HCC病灶,直径1.8-6.5厘米;4例有可用结果的患者血清甲胎蛋白均低于10 ng/mL。
- 4例患者接受肝切除术,1例接受放射栓塞治疗;3例肝切除患者相邻肝组织未见明显炎症或纤维化;2例患者在肝切除后22和26个月出现HCC复发;所有患者均存活,自HCC诊断起生存时间26-153个月。
关键数值与推荐
- AHP患者中HCC发生率为1.5%(5/327)。
- HCC诊断中位年龄69岁(范围61-74岁)。
- 所有4例有可用结果的患者血清甲胎蛋白低于10 ng/mL。
- HCC病灶直径1.8-6.5厘米。
- 作者建议AHP患者无论有无临床发作,均应自50岁起筛查HCC。
临床怎么用
- 作者建议AHP患者无论有无临床发作,均应自50岁起筛查HCC。
- AHP中肝癌发生的发病机制未知,需要进一步研究。
局限性
- AHP中肝癌发生的发病机制未知,需要进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The risk for hepatocellular carcinoma (HCC) is increased in acute hepatic porphyrias (AHP). The aim of this study was to explore the clinicopathologic characteristics, outcomes, and frequency of HCC in patients with AHP in the United States. APPROACH AND RESULTS: This cross-sectional analysis evaluated patients with HCC in a multicenter, longitudinal study of AHP. Among 327 patients with AHP, 5 (1.5%) were diagnosed with HCC. Of the 5 HCC cases, 4 had acute intermittent porphyria and 1 had variegate porphyria, confirmed by biochemical and/or genetic testing. All patients were white females, with a median age of 27 years (range 21-75) at diagnosis. The median age at HCC diagnosis was 69 years (range 61-74). AHP was asymptomatic in 2 patients; 2 reported sporadic attacks; and 1 reported recurrent attacks (>4 attacks/year). All patients had a single HCC lesion on liver imaging that was 1.8-6.5 centimeters in diameter. Serum alpha fetoprotein levels were below 10 ng/mL in all 4 patients with available results. Four patients underwent liver resection, and 1 was treated with radioembolization. No significant inflammation or fibrosis was found in adjacent liver tissues of 3 patients who underwent liver resection. Two patients developed recurrence of HCC at 22 and 26 months following liver resection. All patients are alive with survival times from HCC diagnosis ranging from 26-153 months. CONCLUSION: In this U.S. study, 1.5% of patients with AHP had HCC. HCC in AHP occurred in the absence of cirrhosis, which contrasts with other chronic liver diseases. Patients with AHP, regardless of clinical attacks, should be screened for HCC, beginning at age 50. The pathogenesis of hepatocarcinogenesis in AHP is unknown and needs further investigation.
引用
- Saberi B, Naik H, Overbey JR, et al. Hepatocellular Carcinoma in Acute Hepatic Porphyrias: Results from the Longitudinal Study of the U.S. Porphyrias Consortium. Hepatology. 2020. PMID: 32681675. doi:10.1002/hep.31460
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。